期刊文献+

蜂胶中总黄酮和总多酚的最佳提取工艺 被引量:1

The Optimum Conditions for Extration of Flavonoids and Polyphenols from Propolis
暂未订购
导出
摘要 目的研究蜂胶中总黄酮和总多酚的最佳提取工艺参数和各因素的影响.方法设计正交实验,采用冷浸法、水浴法和超声法提取总黄酮和总多酚.结果采用超声波法,其提取总黄酮最佳工艺参数为乙醇浓度80%,超声时间30 min、料液比1:16;其提取总多酚最佳工艺参数为乙醇浓度90%、提取时间15 min、料液比1:16.结论 3种提取方程法相比较,超声波法较佳. Objective To study the optimum conditions for ectraction of flavonoids and poly phenols from propolis.Method We studied the optimum conditions and the significance of the influencing factors for the extraction of flavonoids and polyphenols from Propolis with merceration,water bath and ultrasonic wave by using orthoganol design.Results The optimal processing parameters of ultrasonic method extracting flavonoids were as following:the concentration of ethanol was 80%,extracting time was 30 min,material liquid ratio was 1:16.Optimal processing parameters of ultrasonic method extracting polyphenols were as following: the concentration of ethano was 90%,extracting time was 15 min,material liquid ratio was 1:16.Conclusion ultrasonic method is the best in the three extraction methods.
出处 《昆明医学院学报》 2011年第12期8-13,共6页 Journal of Kunming Medical College
基金 国家自然科学基金资助项目(30960424) 云南省自然科学基金资助项目(2007CA011)
关键词 蜂胶 黄酮 多酚 正交实验 提取工艺 Propolis Flavonoids Polyphenols Orthoganol design Extraction process
  • 相关文献

参考文献6

  • 1刘青云,徐先祥.蜂胶的药理作用研究进展[J].安徽医药,2007,11(1):1-3. 被引量:33
  • 2刘海鹏,王钦茂.蜂胶治疗口腔疾病的药理作用和临床应用现状[J].中国临床药理学与治疗学,2002,7(4):381-384. 被引量:22
  • 3BRUSCHI M L,JONES D S.Semisolid systems containingpropolis for the treatment of periodontal disease:in vitrorelease kinetics,,syringeability,rheological,textural,andmucoadhesive propertiesJournal of Pharmaceutical Sciences,2007.
  • 4Gamze Bozcuk Erdem,Seval Olmez.Inhibitory effect of Bursa propolis on dental caries-formation in rats inoculated with Streptococcus sobrinus,2004.
  • 5Koo H,Pearson SK,Scott-Anne K,et al.Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in ratsOral Microbiology and Immunology,2002.
  • 6Arjun H. Banskota,Yasuhiro T,et al.Recent progress in pharmacological research of propolisPhytotherapy Research,2001.

二级参考文献53

共引文献52

同被引文献17

  • 1刘治军.体内药物相互作用研究进展[J].继续医学教育,2006,20(28):5-9. 被引量:3
  • 2Liu YT, Hao HP, Liu CX, et al. Drugs as CYP3A probes, inducers, and inhibitors[ J]. Drug Metab Rev,2007,39(4) :699-721.
  • 3Michalets EL. Update: clinically significant cytochrome P450 drug interactions [ J ]. Pharmacotherapy, 1998,18 ( 1 ) :84-112.
  • 4Pelkonen 0, Maenpaa J, Taavitsainen P, et al. Inhibition and induc- tion of human cytochrome CYP (CYP) enzymes [ J ]. Xenobiotica, 1998,28 ( 12 ) : 1203-1253.
  • 5Kim YG, Kang KW. Application of drug metabolism and phammcoki- netics for new drug development [ J ]. Arch Pharm Res, 2011,34 (11) :1769-1771.
  • 6Hachad H, Ragueneau-Majlessi 1, Levy RH. A useful tool for drug interaction evuation: the University of Washington Metabolism and Transport Drug Interaction Database [ J ]. Hum Genomlcs, 2010,5 ( 1 ) :61-72.
  • 7Tang JC, Yang H, Song XY, et al. Inhibition of cytochmme P450 enzymes by rbein in rat liver microsomes[ J]. Phytother Res,2009,23 (2) :159-164.
  • 8Iwata H, Tezuka Y, Kadota S, et al. Identification and characteriza- tion of potent CYP3A4 inhibitors in Schisandra fruit extract[ J]. Drug Metab Dispos,2004,32(12 ) :1351-1358.
  • 9Kimura Y, Ito H, Ohnishi R, et al. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity [ J]. Food Chem Toxicol,2010,48 ( 1 ) :429-435.
  • 10Li C, Lee MY, Choi JS. Effects of silybinin, CYP3A4 and P-glyco- protein inhibitor in vitro, on the bioavailability of loratadine in rats [J]. Pharmazie,2010,65(7) :510-514.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部